|
C2ORF56 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.51499999999838E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.33650000000429E-06 |
| Normal-vs-Stage2 |
8.586000E-01 |
| Normal-vs-Stage3 |
1.923660E-02 |
| Normal-vs-Stage4 |
1.004080E-02 |
| Stage1-vs-Stage2 |
4.500000E-03 |
| Stage1-vs-Stage3 |
1.080040E-01 |
| Stage1-vs-Stage4 |
8.004600E-01 |
| Stage2-vs-Stage3 |
1.205780E-01 |
| Stage2-vs-Stage4 |
4.158000E-02 |
| Stage3-vs-Stage4 |
3.892600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.61489999999898E-05 |
| Normal-vs-AfricanAmerican |
5.767600E-02 |
| Normal-vs-Asian |
2.59989999995547E-06 |
| Caucasian-vs-AfricanAmerican |
3.295800E-01 |
| Caucasian-vs-Asian |
4.377600E-02 |
| AfricanAmerican-vs-Asian |
9.617700E-03 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.018040E-04 |
| Normal-vs-Female |
2.248600E-04 |
| Male-vs-Female |
2.125400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.78140000037541E-07 |
| Normal-vs-Age(41-60Yrs) |
8.875500E-03 |
| Normal-vs-Age(61-80Yrs) |
3.323900E-02 |
| Normal-vs-Age(81-100Yrs) |
3.775400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.293640E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.548400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.658400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.254600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.714400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.674600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.632000E-02 |
| Classical-VS-Follicular |
1.036880E-04 |
| Classical-VS-Other |
3.522000E-01 |
| Classical-VS-Normal |
1.7133999996588E-07 |
| Tall-VS-Follicular |
7.576800E-01 |
| Tall-VS-Other |
1.984290E-02 |
| Tall-VS-Normal |
3.594800E-01 |
| Follicular-VS-Other |
3.334400E-02 |
| Follicular-VS-Normal |
5.662800E-01 |
| Other-VS-Normal |
4.567200E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.196300E-02 |
| Normal-vs-N1 |
1.179080E-04 |
| N0-vs-N1 |
2.318000E-03 |
|
|
